CMS certification 503300
Seattle Children's Hospital
4800 Sand Point Way NE, PO Box C-5371, Seattle, WA 98105
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.
Not reported for this hospital
CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.
Clinicians registered at this address
1,872 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 41 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Pediatrics | 534 |
| Physician Assistant | 62 |
| Pediatric Hematology-Oncology | 59 |
| Dietitian, Registered | 54 |
| Pediatric Anesthesiology | 52 |
| Pediatric Cardiology | 47 |
| Pediatric Critical Care Medicine | 44 |
| Hospitalist | 42 |
| Pharmacist | 41 |
| Pediatric Emergency Medicine | 36 |
| Clinical | 33 |
| Clinical Child & Adolescent | 32 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $7.6M
- 2020 $8.5M
- 2021 $15.4M
- 2022 $12M
- 2023 $10.5M
- 2024 $14.2M
- 2025 $24.9M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Royalties and licensing fees | $19.2M | 22 |
| Space rental and facility fees | $37,350 | 3 |
| Medical devices and supplies on long-term loan | $9,554 | 8 |
| Faculty and speaker fees for medical education | $8,500 | 1 |
| Grants | $8,000 | 2 |
| Debt forgiveness | $2,806 | 4 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Celgene Corporation | $14.3M | 6 |
| E.R. Squibb & Sons, L.L.C. | $5.8M | 2 |
| Pfizer INC. | $1.2M | 57 |
| Regeneron Pharmaceuticals, Inc. | $394,955 | 52 |
| Eli Lilly and Company | $280,655 | 10 |
| Sarepta Therapeutics, Inc. | $274,373 | 23 |
| Merck Sharp & Dohme LLC | $273,047 | 10 |
| Rhythm Pharmaceuticals, Inc. | $225,337 | 112 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Phase 2, Multicenter, Open-Label Study Of CC-97540 (BMS-986353), CD19-Targeted NEXT CAR T Cells, in Participants with Active SLE (Including Lupus N… Celgene Corporation · NCT07015983 | $900,000 |
| A PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF 06939926 FOR THE TREATMENT OF DUCHENN… PFIZER INC. | $464,765 |
| UWASHRSV SEROEPIDEMIOLOGY AND ANTIBODY TRANSFER AMONG PREGNANT WOMEN AND PRETERM INFANTS PFIZER INC. | $410,459 |
| 5051-201 Sarepta Therapeutics, Inc. | $259,546 |
| SCRI-PLAT-06 Trial for SCRI-CD3DARIC Regeneron Pharmaceuticals, Inc. | $242,896 |
| An Open-label, First-in-human, Dose-escalation Study of SAR443579 Administered as Single Agent by Intravenous Infusion in Patients With Relapsed or R… SANOFI US SERVICES INC. · NCT05086315 | $208,939 |
| Risk factors for acquisition and virus specific humoral immunity following respiratory syncytial virus and human metapneumovirus infections in adult … Merck Sharp & Dohme LLC | $135,516 |
| INVOS CathLab Medtronic, Inc. | $134,093 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Seattle Children's Hospital
Does Seattle Children's Hospital have an emergency room?
Yes. CMS lists emergency services at Seattle Children's Hospital.
Does Seattle Children's Hospital receive money from drug and device companies?
Drug and device makers reported $24.9M in payments to Seattle Children's Hospital for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.